Search
for
Sort by
Research 361–390 of 1000+
- Ameliorative Impact of High Inositol Diet on the Insulin Resistance and Metabolite Hormones among Women with Polycystic Ovary Syndrome
- Finasteride
- Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Incidence, complications and therapeutic evaluation of clinical hypothyroidism in different breeds of dogs
- Androgens/Androgen Receptor in the Management of Skin Diseases
- An Indian Evidence-Based Study of Prevalence, Phenotypic Features, Lifestyle Modifications of Polycystic Ovarian Syndrome Patients
- Lean Women with Polycystic Ovary Syndrome
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- Vitamin B<sub>3</sub> (niacin), B<sub>6</sub>, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
- A Study on the Clinical and Hormonal Profile of Polycystic Ovarian Syndrome Patients Attending a Tertiary Care Hospital: A Descriptive Cross-sectional Study
- Association of single nucleotide polymorphisms in the <i>RAB5B</i> gene 3′UTR region with polycystic ovary syndrome in Chinese Han women
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Association of insulin resistance with polycystic ovary syndrome phenotypes and patients’ characteristics: a cross-sectional study in Iran
- Diagnosis of polycystic ovaries syndrome: establishment of reference values of nine hormones on Maglumi X- 8
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Medicinal and cosmetic products used in treatment of hair loss
- Lab Quality Management and Methodology
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Clinical use of 5α-reductase inhibitors
- Finasteride
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Effective medical treatment for common baldness in women
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)